Skip to content

Study to investigate a proportion of adults with unresectable pancreatic cancer prescribed pancreatin.

License

Notifications You must be signed in to change notification settings

opensafely/PaCa_Enzyme_Rx

Repository files navigation

Pancreatic enzyme supplementation in people with pancreatic cancer, with the project on Pancreatic cancer care in the COVID-19 pandemic

View on OpenSAFELY

Details of the purpose and any published outputs from this project can be found at the link above.

The contents of this repository MUST NOT be considered an accurate or valid representation of the study or its purpose. This repository may reflect an incomplete or incorrect analysis with no further ongoing work. The content has ONLY been made public to support the OpenSAFELY open science and transparency principles and to support the sharing of re-usable code for other subsequent users. No clinical, policy or safety conclusions must be drawn from the contents of this repository.

About the OpenSAFELY framework

The OpenSAFELY framework is a Trusted Research Environment (TRE) for electronic health records research in the NHS, with a focus on public accountability and research quality.

Read more at OpenSAFELY.org.

Licences

As standard, research projects have a MIT license.

About

Study to investigate a proportion of adults with unresectable pancreatic cancer prescribed pancreatin.

Resources

License

Stars

Watchers

Forks

Releases

No releases published

Packages

No packages published

Languages